Automated full body tumor segmentation in DOTATATE PET/CT for neuroendocrine cancer patients

被引:2
|
作者
Santilli, Alice [1 ]
Panyam, Prashanth [1 ]
Autz, Arthur [1 ]
Wray, Rick [1 ]
Philip, John [2 ]
Elnajjar, Pierre [1 ]
Swinburne, Nathaniel [1 ]
Mayerhoefer, Marius [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Hlth Informat, York Ave, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
Automatic segmentation; nnUnet; Neuroendocrine tumor; PET; DOTATATE; Radiology; Tumor burden;
D O I
10.1007/s11548-023-02968-1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
PurposeNeuroendocrine tumors (NETs) are a rare form of cancer that can occur anywhere in the body and commonly metastasizes. The large variance in location and aggressiveness of the tumors makes it a difficult cancer to treat. Assessments of the whole-body tumor burden in a patient image allow for better tracking of disease progression and inform better treatment decisions. Currently, radiologists rely on qualitative assessments of this metric since manual segmentation is unfeasible within a typical busy clinical workflow.MethodsWe address these challenges by extending the application of the nnU-net pipeline to produce automatic NET segmentation models. We utilize the ideal imaging type of 68Ga-DOTATATE PET/CT to produce segmentation masks from which to calculate total tumor burden metrics. We provide a human-level baseline for the task and perform ablation experiments of model inputs, architectures, and loss functions.ResultsOur dataset is comprised of 915 PET/CT scans and is divided into a held-out test set (87 cases) and 5 training subsets to perform cross-validation. The proposed models achieve test Dice scores of 0.644, on par with our inter-annotator Dice score on a subset 6 patients of 0.682. If we apply our modified Dice score to the predictions, the test performance reaches a score of 0.80.ConclusionIn this paper, we demonstrate the ability to automatically generate accurate NET segmentation masks given PET images through supervised learning. We publish the model for extended use and to support the treatment planning of this rare cancer.
引用
收藏
页码:2083 / 2090
页数:8
相关论文
共 50 条
  • [41] Variability of 68Ga-DOTATATE Uptake on PET/CT Among Different Neuroendocrine Tumor Grades
    Waits, Timothy
    Jayavarapu, Ravi
    Chauhan, Arran
    Oates, M.
    Anthony, Lowell
    El Khouli, Riham
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [42] The value of 68Gallium-DOTATATE PET/CT in sinonasal neuroendocrine tumor management: A case series
    Liu, Katherine Y.
    Goldrich, David Y.
    Ninan, Sen J.
    Filimonov, Andrey
    Lam, Hansen
    Govindaraj, Satish
    Iloreta, Alfred Marc
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (06): : E30 - E40
  • [43] 68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients
    Fendler, Wolfgang Peter
    Barrio, Martin
    Spick, Claudio
    Allen-Auerbach, Martin
    Ambrosini, Valentina
    Benz, Matthias
    Bluemel, Christina
    Grewal, Ravinder Kaur
    Lapa, Constantin
    Miederer, Matthias
    Nicolas, Guillaume
    Schuster, Tibor
    Czernin, Johannes
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 307 - 311
  • [44] Inter- and intra-tumor heterogeneity on Gallium-68 DOTATATE/ DOTATOC PET/CT predicts response to Lutetium-177 DOTATATE PRRT in Neuroendocrine Tumor Patients
    Jain, Sanchay
    Dundar, Ayca
    Zamboni, Camila
    Loeffler, Bradley
    Graves, Stephen
    Pollard, Janet
    Dillon, Joseph
    Graham, Michael
    Menda, Yusuf
    Mott, Sarah
    Shariftabrizi, Ahmad
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [45] Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor
    Chan, Mico
    Schembri, Geoffrey Paul
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (02) : 108 - 109
  • [46] Role of 68Ga-DOTATATE PET/CT in evaluation of patients with lung neuroendocrine tumors
    Kunikowska, J.
    Matyskiel, R.
    Zemczak, A.
    Pawlak, D.
    Krolicki, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S188 - S188
  • [47] FUNCTIONAL IMAGING WITH 68GA-DOTATATE PET/CT SCAN IN PATIENTS WITH NEUROENDOCRINE TUMOURS
    Woo, J.
    Lee, S. T.
    Berlangieri, S.
    Poon, A. M. T.
    Pathmaraj, K.
    Sachinidis, J.
    Chan, G. J.
    Scott, A. M.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 8 - 8
  • [48] Use of full-dose contrast-enhanced CT for extrahepatic staging using Gallium-68-DOTATATE PET/CT in patients with neuroendocrine tumors
    Apitzsch, Jonas
    Verburg, Frederik Anton
    Mottaghy, Felix
    Heinzel, Alexander
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2021, 27 (04) : 573 - 579
  • [49] Dotatate PET/CT Tumor Volume as a Predictor for Outcome in Patients with Metastatic Gastro-EnteroPancreatic Neuroendocrine Tumors Undergoing Surgical Debulking
    Abou Azar, Sara
    Feinberg, Nicholas
    Appelbaum, Daniel
    Pu, Yonglin
    Lee, Frances T.
    Schwarz, Jason L.
    Williams, Jelani
    Nordgren, Rachel
    Keutgen, Xavier M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S470 - S470
  • [50] Comparison of the Effectiveness of 68Ga-DOTATATE PET/CT and 111In-Octreotide SPECT in Patients With Somatostatin Positive Neuroendocrine Tumor
    Kumar, Meena
    Broline, Shelly
    Amerinia, Reza
    Thamake, Sanjay I.
    Ranganathan, David
    Tworowska, Izabela
    Delpassand, Ebrahim S.
    PANCREAS, 2015, 44 (02) : 355 - 355